Diana Shipping launches hostile tender offer for Genco at $23.50/share, below current market price

summarizeSummary

Diana Shipping Inc. has formally launched a hostile tender offer to acquire all outstanding shares of Genco Shipping & Trading Ltd. for $23.50 per share in cash, a price currently below Genco's market trading value, escalating a multi-month corporate battle.

check_boxKey Events

• Hostile Tender Offer Initiated

  Diana Shipping, through its subsidiary 4 Dragon Merger Sub Inc., formally commenced a tender offer to acquire all outstanding Genco shares for $23.50 per share in cash. The offer is scheduled to expire on June 2, 2026.

• Offer Price Below Market

  The $23.50 per share offer is currently below Genco's market trading price of $23.98 and the last closing price of $24.53, despite being a 31% premium to Genco's undisturbed price on November 21, 2025, before Diana's initial bid.

• Fully Financed Acquisition

  The offer is not subject to any financing condition, backed by $1.433 billion in committed financing, reducing execution risk for Diana.

• Conditional on Board Cooperation

  The offer is contingent on Genco entering a definitive merger agreement, a majority of shares being tendered (including Diana's 14.8% stake), and the removal of Genco's poison pill, conditions Genco's board has previously resisted.

auto_awesomeAnalysis

This SC TO-T filing signifies a major escalation in the hostile takeover attempt by Diana Shipping Inc. for Genco Shipping & Trading Ltd. By formally launching a tender offer, Diana is taking its acquisition proposal directly to Genco shareholders, bypassing the resistant Genco board. While the $23.50 per share offer represents a substantial premium to Genco's stock price prior to Diana's initial bid, it is notably below Genco's current market trading price of $23.98 and the last closing price of $24.53. This suggests that the market anticipates either a higher bid or a successful defense by Genco. The offer is fully financed, reducing execution risk for Diana, but remains conditional on Genco's board agreeing to a merger agreement and dismantling its "poison pill" defense. This move puts direct pressure on Genco's shareholders to decide on the offer, while Diana simultaneously pursues a proxy contest to replace Genco's board, highlighting a determined, multi-pronged effort to gain control. The outcome will depend on shareholder response and Genco's board's next steps in this ongoing corporate battle.